Congenica Receives CE Mark for Genomic Analysis Software
Congenica Receives CE Mark for Genomic Analysis Software Cambridge, United Kingdom - 202 1 - Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people's lives, today announces that its genomic interpretation software is now CE marked under the In Vitro Diagnostics Directive (98/79/EC). With the In Vitro Diagnostic (IVD) designation, Congenica's clinical decision support platform can make the transition from research to clinical use and be applied to the clinical diagnosis of patients with rare hereditary genomic disorders. The plat...
Source: finanznachrichten.de